On April 3, 2023 Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, reported that James Dentzer, President and Chief Executive Officer of Curis, will participate at the following conferences (Press release, Curis, APR 3, 2023, View Source [SID1234629742]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Cantor Fitzgerald Future of Oncology Symposium, being held virtually from April 3 – 5, 2023. Presentation details are as follows:

Format: Panel Presentation
Date: Wednesday, April 5, 2023
Time: 12:00 PM ET
A live webcast and archived replay of the panel discussion will be available to registered attendees of the symposium and can be accessed here or through the symposium website.
The 22nd Annual Needham Virtual Healthcare Conference being held on April 17 – 20, 2023. Presentation details are as follows:

Format: Company Presentation
Date: Thursday, April 20, 2023
Time: 2:15 PM ET